GHK-Cu Copper Peptide: Complete Protocol and Blood Work Guide (2026)

The Peptide That Declines With Age -- And What That Means

GHK-Cu (Glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found in human blood plasma, saliva, and urine. At age 20, plasma GHK-Cu concentration is approximately 200 ng/mL. By age 60, it has fallen to under 80 ng/mL -- a greater than 60% decline.

This decline is not cosmetic. GHK-Cu is one of the primary signaling molecules that maintains tissue repair capacity throughout the body. The genes it activates -- over 4,000 of them according to genomic analysis -- govern collagen production, antioxidant defense, anti-inflammatory signaling, and cellular repair across essentially every tissue type.

The logic of GHK-Cu supplementation is straightforward: restore levels that have declined with aging, and restore the downstream biological activity that those levels support.

What GHK-Cu Actually Does

Collagen and extracellular matrix. GHK-Cu stimulates collagen synthesis (types I, III, and IV), elastin production, and proteoglycan formation -- the three primary structural components of healthy skin, tendons, and connective tissue. This is why users consistently report improved skin quality: reduced fine lines, improved texture, and a visible improvement in skin density.

Antioxidant upregulation. GHK-Cu upregulates superoxide dismutase (SOD) and catalase -- two of the body's primary antioxidant enzymes. Oxidative stress is a major driver of cellular aging and inflammation. GHK-Cu addresses it at the enzymatic level rather than through antioxidant supplementation.

Anti-inflammatory signaling. GHK-Cu inhibits NF-kB, one of the primary transcription factors driving systemic inflammation. This is additive to BPC-157 anti-inflammatory effects and works through a different pathway.

Wound healing and tissue regeneration. GHK-Cu accelerates wound healing, promotes angiogenesis (complementary to BPC-157), and reduces scar tissue formation through organized collagen deposition rather than disorganized fibrotic tissue.

Hair follicle stimulation. GHK-Cu has evidence for promoting hair follicle growth and reducing hair loss -- this is one of its most searched applications and has some of the strongest topical evidence.

The Critical Dose Response: More Is Not Better

This is the most important thing to understand about GHK-Cu. It follows a classic hormetic bell curve dose response:

This is one of the few peptides in the longevity toolkit where more is definitively not better. Stick to 1-2 mg daily. Most experienced users use 1 mg daily for ongoing protocols and 2 mg daily for intensive healing cycles.

Standard Protocol

Dose: 1-2 mg subcutaneous daily

Route: Subcutaneous injection, abdominal or near target tissue

Timing: Any time of day -- no food restriction requirement

Cycle: 8-12 weeks, then reassess

Stack: Most effective as part of the Glow Stack (BPC-157 + TB-500 + GHK-Cu)

For skin-focused protocols, some users split the dose: 0.5 mg subcutaneous plus topical GHK-Cu serum applied to the face. The topical form has strong evidence for skin specifically, though the injectable form has broader systemic reach.

Blood Work to Monitor on GHK-Cu

Serum copper: GHK-Cu delivers copper to tissues. Target range 90-130 mcg/dL. Extended use can elevate serum copper -- particularly relevant in users who already have elevated copper from dietary sources or other supplementation. Check at baseline and at 6 weeks.

Serum zinc: Copper and zinc compete for absorption and share metabolic pathways. High copper from GHK-Cu can suppress zinc status. Target zinc 70-100 mcg/dL. The copper-to-zinc ratio matters more than either value alone -- target ratio under 1.2.

hs-CRP: GHK-Cu anti-inflammatory effects should lower hs-CRP over a 12-week cycle if inflammation was elevated at baseline. Track at baseline and at 12 weeks.

Liver enzymes (ALT, AST): Copper metabolism is primarily hepatic. If using GHK-Cu long-term, periodic liver enzyme monitoring is prudent. Elevated ALT with GHK-Cu use warrants a pause and copper level check.

Frequently Asked Questions

How long before GHK-Cu effects are visible?

Skin quality improvements are typically reported at 6-8 weeks at therapeutic dose. Collagen remodeling is a slow process -- the full effect of a 12-week cycle is not apparent until the cycle is complete.

Can I use topical GHK-Cu instead of injectable?

For skin-focused applications, topical GHK-Cu has strong evidence and is a reasonable alternative to injectable. For systemic anti-aging, tissue repair, and antioxidant effects, subcutaneous injection has broader reach. Many users use both.

Does GHK-Cu interact with other peptides?

No significant interactions are known. GHK-Cu is commonly stacked with BPC-157 and TB-500 (Glow Stack) and with GH peptides. The mechanisms are additive and non-competing.

Is GHK-Cu safe long-term?

GHK-Cu has a favorable safety profile in available research. The main long-term consideration is copper accumulation -- monitoring serum copper quarterly with long-term use is prudent. Wilson disease (copper metabolism disorder) is a contraindication.

What does the Glow Stack add over BPC-157 alone?

BPC-157 handles vascular supply and inflammation. TB-500 handles cellular recruitment. GHK-Cu handles extracellular matrix quality -- ensuring new tissue is deposited as organized collagen rather than disorganized scar tissue. The three mechanisms are complementary across the entire healing process.

The information in this article is for educational purposes only. It does not constitute medical advice. Always consult a licensed healthcare provider before starting any peptide protocol.

Written by Ryan -- Founder, MyProtocolStack. Last Updated: April 2026.